Treatment with 5-MTP alleviated renal fibrosis, suppressed IκB/NF-κB signaling pathway, and improved Keap1/Nrf2 signaling pathway in mice with UUO or ischemia/reperfusion injury and in human kidney cells 33. Here, NFE2L2 is linked to renal fibrosis.